Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
, 29 (2), 136-40

High Prevalence of Adrenal Suppression During Acute Illness in Hospitalized Patients Receiving Megestrol Acetate

Clinical Trial

High Prevalence of Adrenal Suppression During Acute Illness in Hospitalized Patients Receiving Megestrol Acetate

A R Chidakel et al. J Endocrinol Invest.


Introduction: Megestrol acetate (MA) is a progestational agent used for palliation of breast and endometrial cancer. The drug promotes weight gain via appetite stimulation. This property has led to widespread use in patients with wasting illnesses. Increasing numbers of reports suggest glucocorticoid activity.

Objective: Unrecognized adrenal suppression may result from MA use. This is the first study to examine the prevalence of adrenal suppression in hospitalized patients treated with MA.

Subjects and design: This is a cross-sectional study of hospitalized patients receiving MA compared to control subjects. Morning cortisol levels, endocrine signs and symptoms, and duration of MA therapy were evaluated in 28 hospitalized medical patients treated with MA, and 21 control patients admitted to the same hospital service during the study period.

Results: Median cortisol levels were significantly lower in patients using MA vs controls (160 vs 386 nmol/l, p=0.003). Forty-three percent of subjects on MA demonstrated morning cortisol levels below the normal range (138-690 nmol/l), compared with 10% of controls (p=0.013). Ninety-three percent of subjects taking MA had morning cortisol levels below the level that excludes adrenal insufficiency in hospitalized patients (497 nmol/l) vs 71% of controls (p=0.06).

Conclusions: MA use is associated with significant adrenal suppression in acutely ill individuals. This should alert physicians to the possibility of adrenal insufficiency and the need to assess for signs or symptoms of adrenal insufficiency, and mandates a low threshold for testing adrenal function in hospitalized patients taking MA.

Similar articles

See all similar articles

Cited by 3 articles


    1. AIDS. 2000 Feb 18;14(3):321-4 - PubMed
    1. Clin Endocrinol (Oxf). 1995 Jan;42(1):91-3 - PubMed
    1. Arch Intern Med. 1997 Aug 11-25;157(15):1651-6 - PubMed
    1. Br J Cancer. 1999 Feb;79(3-4):495-500 - PubMed
    1. Biochem Pharmacol. 1983 May 1;32(9):1511-8 - PubMed

Publication types

LinkOut - more resources